Rezultati pretraživanja
  1. 4. velj
  2. 4. velj

    More from on the HER2Climb study. "HER2 Breast Cancer Treatment Effective on Brain Metastases"

  3. 4. velj

    Didn't make it to ? Check out what you missed! Now available, useful Practice Aids from our activity featuring Professor Peter Schmid, Dr. Leisha Emens, and Dr. Heather McArthur ().

  4. 3. velj

    Phase III Study of Oral Paclitaxel in Metastatic Breast Cancer : Gerardo Antonio Umanzor, MD of Liga Contra el Cáncer on paclitaxel shown to be superior to IV paclitaxel on confirmed response and survival with less neuropathy: a Phase III…

  5. 2. velj
  6. 2. velj

    Great Update! Advocate table from right: Melissa, Chris, Tim, me, Tori (Jill behind Tori at other table), Bobbie, and Linda. Tori and I are waving both hands for the camera!

  7. 2. velj

    Tori was brilliant as she shared the advocacy experience from at the Ohio State SABCS Update. "Nothing about us without us."

  8. 1. velj
  9. Saturday well spent with co-fellow Dione Quiroga at the review learning about advances in

  10. 1. velj

    Dr. Aiza Obando started the Radiology session this afternoon. Dr. Barrio will follow with a surgery update from & Dr. Crownover to end day 2 sessions with an update on radiotherapy from San Antonio.

  11. 1. velj

    gives overview of his 5 decades in medicine and treating breast cancer

  12. 1. velj

    Getting better at the ‘podium selfie’! Thanks to & Bhuvana Ramaswamy for organizing the review - full house >225 attendees!

  13. 1. velj

    SOHPIA Study in Metastatic Breast Cancer : Hope Rugo, MD of discusses the SOPHIA Study. _____________ MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing…

  14. 1. velj

    KEYNOTE 522 (chemo+/-pembro) and NeoTRIP (carbo+nab-paclitaxel +/- atezo) showing conflicting data on neoadj immunotherapy for triple negative breast cancer

    Prikaži ovu nit
  15. 1. velj

    Dr.Julia White giving fantastic overview on advances and opportunities to personalizing radiation decisions review.

    Prikaži ovu nit
  16. 1. velj
  17. 1. velj

    Prognostic Marker in Operable Breast Cancer : Luca Malorni, MD of Prato Hospital discusses a marker in operable breast cancer at SABCS 19. __________ The study is a retrospective analysis on serum samples from a randomized clinical trial…

  18. 31. sij
  19. 30. sij

    - - Dr C Kent Osborne speaks during the Opening Session of the 2019 symposium.

  20. 30. sij

    APHINITY Update Supports Benefit of Pertuzumab-Based Triplet in Early HER2-Positive, Node-Positive Breast Cancer

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.